Pharvaris (PHVS) Cash & Equivalents (2019 - 2026)
Pharvaris (PHVS) reported Cash & Equivalents of $369.96 million for Q2 2026, up 63.8% from $225.91 million a year earlier but down 100.0% from the prior quarter.
Powered by 
Analysis
Pharvaris (PHVS) Cash & Equivalents (2019 - 2026) Analysis & Trends
At the end of FY2025, Pharvaris posted Cash & Equivalents of $329.54 million, up 8.5% from FY2024.
- Cash & Equivalents has a five-year compound annual growth rate of 24.0% (FY2020 to FY2025).
- By year, Cash & Equivalents came in at $303.84 million in FY2024 (-28.2%), $423.2 million in FY2023 (+91.8%), $220.65 million in FY2022 (-10.9%) and $247.75 million in FY2021 (+120.0%).
- Five-year quarterly Cash & Equivalents spans a low of $165.11 million in Q4 2022 and a high of $400.15 trillion in Q1 2024.
- Year over year, Cash & Equivalents gained in four of the last seven quarters, with growth averaging 0.7%.
- The high point for year-over-year Cash & Equivalents in five years was Q3 2021 (growth of 426.1%); the low point was Q1 2025 (a decline of 100.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $289.13 trillion (Q1 2026), $339.53 million (Q4 2025) and $384.95 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 13.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.18 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 976.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 6.14 Bn |
| 10 | Pharvaris | 2.07 Bn | -289,124.33 Bn | 85,072.10 | 369.96 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 369.96 Mn |
| Mar 31, 2026 | 289,125.00 Bn |
| Dec 31, 2025 | 339.53 Mn |
| Sep 30, 2025 | 384.95 Mn |
| Jun 30, 2025 | 225.91 Mn |
| Mar 31, 2025 | 248.77 Mn |
| Dec 31, 2024 | 299.98 Mn |
| Sep 30, 2024 | 335,169.03 Bn |
| Jun 30, 2024 | 369.99 Mn |
| Mar 31, 2024 | 400,152.85 Bn |
| Dec 31, 2023 | 174.13 Mn |
| Sep 30, 2023 | 172,387.81 Bn |
| Jun 30, 2023 | 195.12 Mn |
| Mar 31, 2023 | 145,095.66 Bn |
| Dec 31, 2022 | 165.11 Mn |
| Sep 30, 2022 | 199.37 Mn |
| Jun 30, 2022 | 214.89 Mn |
| Mar 31, 2022 | 218.60 Mn |
| Dec 31, 2021 | 239.49 Mn |
| Sep 30, 2021 | 257.79 Mn |
API Access
Pharvaris Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PHVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "PHVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PHVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();